Clinical Lab Molecular Diagnostics Test using QX200 ddPCR Instr.

SOL #: 75N98026Q00356Pre-SolicitationSole Source

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

Bethesda, MD

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Timeline

1
Posted
May 14, 2026
2
Response Deadline
May 24, 2026, 1:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH) intends to award a non-competitive (sole source) contract to Nexus Group LLC for Clinical Laboratory Molecular Diagnostics Test using QX200 ddPCR instrument services. These services are critical for cancer diagnosis, prognosis, and personalized therapies within the Lab of Pathology, CCR. While the intent is sole source, interested parties may submit capabilities for consideration. Responses are due May 28, 2026.

Scope of Work

  • Provide molecular testing services for cancer diagnosis, prognosis, and personalized therapies.
  • Services must be performed using a QX200 ddPCR instrument.

Contract & Timeline

  • Type: Non-competitive (sole source) acquisition, using Simplified Acquisition Procedures (FAR Part 13).
  • Set-Aside: Total Small Business Set-Aside (FAR 19.5) is indicated, though the primary intent is sole source.
  • NAICS: 334516 (Size Standard $34M).
  • Estimated Value: Not expected to exceed the simplified acquisition threshold ($350,000).
  • Response Due: May 28, 2026, at 9:00 AM Eastern time.
  • Published: May 14, 2026.
  • Place of Performance: Bethesda, MD.

Submission & Evaluation

This is not a request for competitive proposals. However, interested parties may identify their interest and capability to perform the required services. Responses should include a technical proposal, cost-price proposal, proposed period of performance, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must have an active registration in SAM.gov. The government reserves the right to proceed non-competitively or conduct a competitive procurement based on responses received.

Contact Information

People

Points of Contact

Roshonna DavisPRIMARY
davisroshonna@mail.nih.gov

Files

Files

Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: May 14, 2026
Clinical Lab Molecular Diagnostics Test using QX200 ddPCR Instr. | GovScope